INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2016

Global prevalence of nonalcoholic fatty liver disease was estimated at 25 percent.

A meta-analysis of 86 studies encompassing 8,515,431 individuals across 22 countries assessed nonalcoholic fatty liver disease epidemiology. Global prevalence was 25.24% (95% CI: 22.10-28.65), with frequent comorbidities including obesity (51.34%) and type 2 diabetes (22.51%). Annual liver-specific mortality was 0.77 per 1,000 person-years in nonalcoholic fatty liver disease and 15.44 per 1,000 in nonalcoholic steatohepatitis.

Study type
Meta-analysis
Who was studied
8,515,431 participants across 86 studies from 22 countries
What was measured
Prevalence, incidence, progression, and mortality of NAFLD and NASH

THE PAPER

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Hepatology, 2016.

PubMed 26707365 ↗DOI 10.1002/hep.28431 ↗

Diabetes & blood sugarGut & microbiomeWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.